142 related articles for article (PubMed ID: 11340370)
21. Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis.
Dane C; Dane B; Cetin A; Erginbas M
Gynecol Endocrinol; 2007 Jul; 23(7):398-403. PubMed ID: 17701771
[TBL] [Abstract][Full Text] [Related]
22. Sex steroid hormones, bone mineral density, and risk of breast cancer.
Kuller LH; Cauley JA; Lucas L; Cummings S; Browner WS
Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):593-9. PubMed ID: 9168001
[TBL] [Abstract][Full Text] [Related]
23. L-thyroxine prevents the bone-conserving effect of HRT in postmenopausal women with subclinical hypothyroidism.
Pines A; Dotan I; Tabori U; Villa Y; Mijatovic V; Levo Y; Ayalon D
Gynecol Endocrinol; 1999 Jun; 13(3):196-201. PubMed ID: 10451812
[TBL] [Abstract][Full Text] [Related]
24. Long-term effects of continuous combined HRT on bone turnover and lipid metabolism in postmenopausal women.
Hart DM; Farish E; Fletcher CD; Barnes JF; Hart H; Nolan D; Spowart K
Osteoporos Int; 1998; 8(4):326-32. PubMed ID: 10024902
[TBL] [Abstract][Full Text] [Related]
25. Effects of raloxifene, hormone replacement therapy, and placebo on bone turnover in postmenopausal women.
Weinstein RS; Parfitt AM; Marcus R; Greenwald M; Crans G; Muchmore DB
Osteoporos Int; 2003 Oct; 14(10):814-22. PubMed ID: 14610642
[TBL] [Abstract][Full Text] [Related]
26. [Postmenopausal hormonal treatment: conventional hormone replacement therapy or tibolone? Effects on bone].
Reginster JY
J Gynecol Obstet Biol Reprod (Paris); 2002 Oct; 31(6):541-9. PubMed ID: 12407324
[TBL] [Abstract][Full Text] [Related]
27. Effect of estrogen replacement therapy upon bone mineral density in thyroxine-treated postmenopausal women with a past history of thyrotoxicosis.
Franklyn JA; Betteridge J; Holder R; Sheppard MC
Thyroid; 1995 Oct; 5(5):359-63. PubMed ID: 8563472
[TBL] [Abstract][Full Text] [Related]
28. Influence of hormone replacement therapy on disease progression and bone mineral density in rheumatoid arthritis.
D'Elia HF; Larsen A; Mattsson LA; Waltbrand E; Kvist G; Mellström D; Saxne T; Ohlsson C; Nordborg E; Carlsten H
J Rheumatol; 2003 Jul; 30(7):1456-63. PubMed ID: 12858441
[TBL] [Abstract][Full Text] [Related]
29. Effects of continuous combined hormone replacement therapy and clodronate on bone mineral density in osteoporotic postmenopausal women: a 5-year follow-up.
Tuppurainen M; Härmä K; Komulainen M; Kiviniemi V; Kröger H; Honkanen R; Alhava E; Jurvelin J; Saarikoski S
Maturitas; 2010 Aug; 66(4):423-30. PubMed ID: 20547017
[TBL] [Abstract][Full Text] [Related]
30. Final 5-year results of Z-FAST trial: adjuvant zoledronic acid maintains bone mass in postmenopausal breast cancer patients receiving letrozole.
Brufsky AM; Harker WG; Beck JT; Bosserman L; Vogel C; Seidler C; Jin L; Warsi G; Argonza-Aviles E; Hohneker J; Ericson SG; Perez EA
Cancer; 2012 Mar; 118(5):1192-201. PubMed ID: 21987386
[TBL] [Abstract][Full Text] [Related]
31. Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study.
Bagger YZ; Tankó LB; Alexandersen P; Hansen HB; Møllgaard A; Ravn P; Qvist P; Kanis JA; Christiansen C
Bone; 2004 Apr; 34(4):728-35. PubMed ID: 15050905
[TBL] [Abstract][Full Text] [Related]
32. Justification for the use of HRT in the long-term prevention of osteoporosis.
Stevenson JC
Maturitas; 2005 Jun; 51(2):113-26. PubMed ID: 15917151
[TBL] [Abstract][Full Text] [Related]
33. Breast cancer after hormone replacement therapy--does prognosis differ in perimenopausal and postmenopausal women?
Baumgärtner AK; Häusler A; Seifert-Klauss V; Schuster T; Schwarz-Boeger U; Kiechle M
Breast; 2011 Oct; 20(5):448-54. PubMed ID: 21652211
[TBL] [Abstract][Full Text] [Related]
34. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study.
Morabito N; Crisafulli A; Vergara C; Gaudio A; Lasco A; Frisina N; D'Anna R; Corrado F; Pizzoleo MA; Cincotta M; Altavilla D; Ientile R; Squadrito F
J Bone Miner Res; 2002 Oct; 17(10):1904-12. PubMed ID: 12369794
[TBL] [Abstract][Full Text] [Related]
35. Effects of exercise on bone mineral density in calcium-replete postmenopausal women with and without hormone replacement therapy.
Going S; Lohman T; Houtkooper L; Metcalfe L; Flint-Wagner H; Blew R; Stanford V; Cussler E; Martin J; Teixeira P; Harris M; Milliken L; Figueroa-Galvez A; Weber J
Osteoporos Int; 2003 Aug; 14(8):637-43. PubMed ID: 12844212
[TBL] [Abstract][Full Text] [Related]
36. Prevention of femoral and lumbar bone loss with hormone replacement therapy and vitamin D3 in early postmenopausal women: a population-based 5-year randomized trial.
Komulainen M; Kröger H; Tuppurainen MT; Heikkinen AM; Alhava E; Honkanen R; Jurvelin J; Saarikoski S
J Clin Endocrinol Metab; 1999 Feb; 84(2):546-52. PubMed ID: 10022414
[TBL] [Abstract][Full Text] [Related]
37. [Mammography changes associated with hormone replacement therapy in post-menopausal patients].
Del Favero C; Rossini G; Tufarulo L; Ciancio ML; Sopransi M; Martegani A; Borghi C; Campi R; Fugazzola C
Radiol Med; 1997 Mar; 93(3):210-3. PubMed ID: 9221411
[TBL] [Abstract][Full Text] [Related]
38. Identification of early postmenopausal women with no bone response to HRT: results of a five-year clinical trial.
Komulainen M; Kröger H; Tuppurainen MT; Heikkinen AM; Honkanen R; Saarikoski S
Osteoporos Int; 2000; 11(3):211-8. PubMed ID: 10824236
[TBL] [Abstract][Full Text] [Related]
39. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism.
Guo CY; Thomas WE; al-Dehaimi AW; Assiri AM; Eastell R
J Clin Endocrinol Metab; 1996 Oct; 81(10):3487-91. PubMed ID: 8855790
[TBL] [Abstract][Full Text] [Related]
40. Does vitamin D strengthen the increase in femoral neck BMD in osteoporotic women treated with estrogen?
Tuppurainen MT; Komulainen M; Kröger H; Honkanen R; Jurvelin J; Puntila E; Heikkinen AM; Alhava E; Saarikoski S
Osteoporos Int; 1998; 8(1):32-8. PubMed ID: 9692075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
